Additionally, Ouyang et al. developed microneedles loaded with the NLRP3 inhibitor MCC950, which enhances wound healing by curtailing inflammation triggered by NLRP3 inflammasome activation due to bacterial infection [38]. Here, NLRP3 is linked to bacterial infectious disease.